In this rare and exclusive interview, the chairman of the Outsourcing Facilities Association sits down with On The Pen to discuss the current landscape of compound tirzepatide.
Www.503bs.org
Share this post
On The Pen With Dave Knapp
Rare Exclusive Interview: OFA Chairman Sits Down with OTP to Talk Tirzepatide Lawsuit
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Appears in episode
On The Pen
Recent Episodes
Share this post